- Home
- AFCG vs NTRB Comparison
AFCG vs NTRB Comparison
Compare AFCG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AFCG | NTRB |
|---|---|---|
| Founded | 2020 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.9M | 71.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AFCG | NTRB |
|---|---|---|
| Price | $2.89 | $4.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.75 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 209.6K | 20.9K |
| Earning Date | 11-12-2025 | 12-03-2025 |
| Dividend Yield | ★ 20.83% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,578,059.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | $4.44 | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 42.92 |
| 52 Week Low | $2.52 | $3.72 |
| 52 Week High | $9.71 | $11.78 |
Technical Indicators
Market Signals| Indicator | AFCG | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 42.81 | 37.59 |
| Support Level | $2.52 | $4.45 |
| Resistance Level | $3.02 | $4.99 |
| Average True Range (ATR) | 0.16 | 0.33 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 59.89 | 31.09 |
Price Performance
Historical ComparisonAbout AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.